WARNING: Company has ~500M O/S...Market Cap $300M = Extremely High
From the company website:
Based on 497.1 million fully diluted, as-converted common shares assuming the full conversion of convertible debt outstanding and 80 million warrants using treasury stock method and 102 million common shares anticipated to be issued on July 30, 2012; not including options
They'll have ~500 million Outstanding Shares. At the Price of $0.50, that gives us Market cap of $250M which is way too high for only one drug that's in the company pipeline. I Don't see how it goes over $0.50
Welcome to $0.30s
Newbies don't listen to pumpers, do your own DD....Everything is listed on the company website.